Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06462820 · ClinicalTrials.gov registry record · Phase 2
SAINT for MDD in an Inpatient Setting Follow-on
A Phase 2 study, sponsored by Magnus Medical.
- Terminated
- Registry status
- Phase 2
- Development phase
- 2
- Enrollment target
NCT06462820: Clinical Trial Phase 2 study, sponsored by Magnus Medical.
NCT06462820 is a Phase 2 study that was terminated before completion, run by Magnus Medical. The registered enrollment target is 2 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06462820, a Phase 2 study, was terminated before completion, sponsored by Magnus Medical.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 2 participants
- Enrollment target
Study Summary
Randomized, multi-site, sham-controlled, double-blinded study
Primary Outcome
Ten item diagnostic questionnaire which psychiatrists use to measure the severity of depressive symptoms in patients with mood disorders. We will assess the difference in MADRS scores/remission rates between the per-protocol active SAINT group compared to those who received per-protocol sham treatment at the immediate post treatment visit.
Interventions
- DEVICE Sham SAINT Stimulation
- DEVICE Active SAINT Stimulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2024-06-30 |
| Est. Completion | 2025-03-06 |
| Phase | Phase 2 |
Why NCT06462820 stopped before completion
NCT06462820 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 2 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Sham SAINT Stimulation is the first listed.
NCT06462820 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06462820 about?
NCT06462820 is a clinical study titled "SAINT for MDD in an Inpatient Setting Follow-on". Randomized, multi-site, sham-controlled, double-blinded study
What is the current status of trial NCT06462820?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 2 participants. The study started on 2024-06-30. Estimated completion is 2025-03-06.
What interventions are being tested in trial NCT06462820?
The interventions under investigation include: Sham SAINT Stimulation (DEVICE), Active SAINT Stimulation (DEVICE).
Who is sponsoring clinical trial NCT06462820?
This trial is sponsored by Magnus Medical, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06462820's enrollment target sits among peer trials
2 2001st of 2000 the lowest of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI